GoodRx Holdings (GDRX) Market Capitalization (2020 - 2026)

GoodRx Holdings has disclosed Market Capitalization across 7 years of filings, most recently posting $979.6 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 44.24% year-over-year to $979.6 million; the TTM figure through Jun 2026 stood at $979.6 million (down 44.24% YoY), while the FY2025 annual figure was $924.3 million, down 48.08% from the prior year.
• Market Capitalization came in at $979.6 million for Q2 2026 at GoodRx Holdings, up from $661.7 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $7.7 billion in Q1 2022 to a low of $661.7 million in Q1 2026.
• Average Market Capitalization over 5 years is $2.3 billion, with a median of $2.0 billion recorded in 2022.
• Year-over-year, Market Capitalization slumped 88.69% in 2022 and jumped 42.71% in 2023.
• Over 5 years, Market Capitalization stood at $1.9 billion in 2022, then jumped by 42.71% to $2.6 billion in 2023, then tumbled by 32.58% to $1.8 billion in 2024, then sank by 48.08% to $924.3 million in 2025, then climbed by 5.99% to $979.6 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $979.6 million in Q2 2026, $661.7 million in Q1 2026, and $924.3 million in Q4 2025.